Home > Insider Trading > Filing (0001455244-10-000038)

Filing Details

Accession Number:: 0001455244-10-000038
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-03-11 12:00:00
Reporting Period:: 2010-03-10

Filing Date:: 2010-03-11
Accepted Time:: 2010-03-11 18:25:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
827809	Qlt Inc	QLTI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1360509	Florian Schonharting	Ostergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No
1360573	Christian Hansen	Ostergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No
1451330	K/S Equity Public Nb	Ostergade 5, 3Rd Floor Dk-1100 Copenhagen K G7	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Shares, No Par Value	Acquisiton	2010-03-10	100	$4.68	7,256,664	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	4,900	$4.69	7,261,564	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	3,600	$4.70	7,265,164	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	100	$4.73	7,265,264	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	3,044	$4.73	7,268,308	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	3,000	$4.74	7,271,308	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	100	$4.77	7,271,408	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	2,000	$4.78	7,273,408	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	100	$4.79	7,273,508	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	2,100	$4.79	7,275,608	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	200	$4.80	7,275,808	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	1,112	$4.80	7,276,920	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	3,006	$4.81	7,279,926	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	300	$4.82	7,280,226	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	3,132	$4.82	7,283,358	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	1,275	$4.83	7,284,633	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	100	$4.83	7,284,733	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	200	$4.84	7,284,933	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	10,611	$4.84	7,295,544	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	22,837	$4.85	7,318,381	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	600	$4.85	7,318,981	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	1,200	$4.86	7,320,181	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	9,569	$4.86	7,329,750	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	700	$4.86	7,330,450	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	600	$4.87	7,331,050	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	4,800	$4.87	7,335,850	No	4	P	Direct
Common Shares, No Par Value	Acquisiton	2010-03-10	1,000	$4.88	7,336,850	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Reported shares are owned directly by NB Public Equity K/S (the "Fund"), and indirectly by the other listed Reporting Owners.
Christian Hansen and Florian Sch?nharting are direct investors in a limited partner in the Fund and directors of Nordic Biotech Advisors ApS, which owns 100% of the shares of NB Public Equity Komplementar ApS, the general partner of the Fund. Each of Messrs. Hansen and Sch?nharting disclaim beneficial ownership in the securities, except to the extent of their pecuniary interest therein.